[
  {
    "cui": "C1334968",
    "cui_name": "Nodular Lymphocyte Predominant Hodgkin Lymphoma",
    "incidence_per_100k": 0.15,
    "prevalence_per_100k": null,
    "metric_type": "incidence",
    "total_cases_per_year": 12000,
    "confidence": 0.62,
    "is_subtype": true,
    "parent_disease": "Hodgkin Lymphoma",
    "reasoning": "NLPHL represents approximately 5-7% of all Hodgkin lymphoma cases. Global Hodgkin lymphoma incidence is ~2.5 per 100k per year (per GLOBOCAN data). Estimated NLPHL incidence at ~0.15 per 100k (~12,000 cases annually). Moderate confidence due to rarity and limited population-based registry data specifically tracking this subtype.",
    "data_quality": "moderate",
    "geographic_variation": "moderate",
    "year_specific": false,
    "data_year": null,
    "source": "GLOBOCAN 2012 (Hodgkin lymphoma aggregate), supplemented with SEER histological subtype distributions",
    "source_url": "https://gco.iarc.fr/",
    "source_type": "registry"
  }
]
